Tanglin Venture Partners

Tanglin Venture Partners is a Bengaluru-based growth-stage venture firm operating with $5M-$25M cheques at Series A and Series B into prominent Indian consumer health and tech-enabled services platforms, with notable exposure to Plum (employee health benefits) signalling preference for category-defining commercial plays in the consumer-and-employer health space. For founders, Tanglin is best positioned as a Series A and B lead for Indian operators building tech-enabled service businesses, employee health platforms, and consumer-facing care delivery models. The right founder profile is an Indian operator with $5M+ revenue traction, clear unit economics, and ambitions to consolidate or define a category in tech-enabled health services or employee benefits. Founders running deep biotech, asset-heavy hospital chains, pure clinical AI software without commercial depth, or pre-revenue plays should not approach. Entry path is via a Tanglin portfolio CEO (Plum, others), Indian growth-stage banking advisers (Avendus, Kotak), or warm introductions from co-investing Indian and US funds (Sequoia, Lightspeed, Tiger). In the pitch, lead with revenue traction, gross retention, unit economics, founder-market fit, and a credible Series B narrative that contemplates international leads. Caveats: AI is not a stated focus, so AI-heavy founders should expect commercial rather than technical diligence and should bring external technical advisors. Tanglin’s deal cadence is selective and concentrated, so cycle times can extend if conviction takes time to build. Term sheets carry standard institutional governance provisions and partners expect active engagement. Confirm reserves and follow-on policy explicitly given the firm’s preference for concentrated positions, and clarify check pacing relative to current fund vintage.